Global hospital acquired infection control market is expected to grow at a steady rate for the forecast period owing to increase in number of surgeries performed in hospital which are highly prone to getting infected in healthcare facilities. Hospital acquired infections are increasing at rapid pace in emerging economies due to presence of large patient pool and shortage of hospital facilities. Adoption of medical nonwovens and disinfectors on a large scale in healthcare industry is a major driver for high demand of hospital acquired infection control. Increasing focus by healthcare facilities for controlling the spread of infection in premises and increasing adoption of infection control policies. Also, stringent policies and norms being implemented in healthcare premises by leading authorities for prevention and control of infection is accelerating the growth of the market. Rapid growth of infrastructural development of hospitals and healthcare facilities is augmenting the rise in market.

Global hospital acquired infection control market is segmented into product, application, technology, disease, end user, regional distribution, and company. Based on regional analysis, North America is expected to dominate the market for the forecast period, 2022-2026. Technological advancements and presence of major market players in the region are the main factor fostering the high demand in the region. Rising disposable income Asia-pacific region is expected to witness fastest incremental growth for the next five years primarily due to growth in the number of hospitals and the increasing prevalence of chronic diseases. Increase in medical tourism activities in emerging economies such as India and China. Rising aging population along with supportive government policies is contributing significantly to the growth of the market.

The major players operating in the global hospital acquired infection control market are Becton, Dickinson and Company, Steris Corporation Ltd., Advanced Sterilization Products, Getinge Group, Kimberly-Clark Corporation, Cantel Medical Corporation, BioMérieux SA, Belimed AG, 3M company, Sterigenics International LLC, Synergy Health PLC, Olympus Corporation Ltd, Danaher Corporation Ltd. (Cepheid), Crosstex International, Inc., Diversey Inc, among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022–2026

Objective of the Study:

  • To analyze the historical growth of the market size of global hospital acquired infection control market from 2016 to 2019.
  • To estimate and forecast the market size of global hospital acquired infection control market from 2020 to 2026 and growth rate until 2026.
  • To classify and forecast global hospital acquired infection control market based on product, allergy type, test, end user, region, and company.
  • To identify dominant region or segment in the global hospital acquired infection control market.
  • To identify drivers and challenges for global hospital acquired infection control market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global hospital acquired infection control market.
  • To identify and analyze the profile of leading players operating in global hospital acquired infection control market.
  • To identify key sustainable strategies adopted by market players in global hospital acquired infection control market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global hospital acquired infection controlmarket using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Allergy diagnostic manufacturing companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to hospital acquired infection control market

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global hospital acquired infection control market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Global Hospital Acquired Infection Control Market, By Product:

    • Assay Kits
    • Instruments
    • Consumables
    • Services
  • Global Hospital Acquired Infection Control Market, By Allergy Type:
    • Food
    • Seasonal
    • Drug
    • Inhalant
    • Anaphylaxis/Contact Allergies
    • Others
  • Global Hospital Acquired Infection Control Market, By Test:
    • In Vivo
    • In Vitro
  • Global Hospital Acquired Infection Control Market, By Test:
    • Hospital
    • Diagnostic Laboratory
    • Academic and Research Institute
    • Others
  • Global Hospital Acquired Infection Control Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • United Kingdom
      • Italy
      • Spain
      • Germany
      • France
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea

o   Middle East & Africa

      • Saudi Arabia
      • South Africa
      • UAE
    • South America

§  Brazil

§  Argentina

§  Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global hospital acquired infection control market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global hospital acquired infection control market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Hospital Acquired Infection Control Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Hospital Acquired Infection Control Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Sterilizers, Disinfectors, Endoscope Reprocessors, Others)

6.2.2.     By Application (Disease Testing, Drug-Resistance Testing)

6.2.3.     By Technology (Phenotypic Methods, Genotypic Methods)

6.2.4.     By Disease (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, UTI, Others)

6.2.5.     By End User (Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Others)

6.2.6.     By Company (2020)

6.2.7.     By Region

6.3.  Product Market Map

7.    Asia-Pacific Hospital Acquired Infection Control Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product

7.2.2.     By Application

7.2.3.     By Technology

7.2.4.     By Disease

7.2.5.     By End User

7.2.6.     By Country

7.3.  Asia-Pacific: Country Analysis

7.3.1.     China Hospital Acquired Infection Control Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Application

7.3.1.2.3.             By Technology

7.3.1.2.4.             By Disease

7.3.1.2.5.             By End User

7.3.2.     India Hospital Acquired Infection Control Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Application

7.3.2.2.3.             By Technology

7.3.2.2.4.             By Disease

7.3.2.2.5.             By End User

7.3.3.     Japan Hospital Acquired Infection Control Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Application

7.3.3.2.3.             By Technology

7.3.3.2.4.             By Disease

7.3.3.2.5.             By End User

7.3.4.     South Korea Hospital Acquired Infection Control Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Product

7.3.4.2.2.             By Application

7.3.4.2.3.             By Technology

7.3.4.2.4.             By Disease

7.3.4.2.5.             By End User

7.3.5.     Australia Hospital Acquired Infection Control Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Product

7.3.5.2.2.             By Application

7.3.5.2.3.             By Technology

7.3.5.2.4.             By Disease

7.3.5.2.5.             By End User

8.    Europe Hospital Acquired Infection Control Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product

8.2.2.     By Application

8.2.3.     By Technology

8.2.4.     By Disease

8.2.5.     By End User

8.2.6.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Hospital Acquired Infection Control Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Application

8.3.1.2.3.             By Technology

8.3.1.2.4.             By Disease

8.3.1.2.5.             By End User

8.3.2.     Germany Hospital Acquired Infection Control Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Application

8.3.2.2.3.             By Technology

8.3.2.2.4.             By Disease

8.3.2.2.5.             By End User

8.3.3.     United Kingdom Hospital Acquired Infection Control Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Application

8.3.3.2.3.             By Technology

8.3.3.2.4.             By Disease

8.3.3.2.5.             By End User

8.3.4.     Italy Hospital Acquired Infection Control Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product

8.3.4.2.2.             By Application

8.3.4.2.3.             By Technology

8.3.4.2.4.             By Disease

8.3.4.2.5.             By End User

8.3.5.     Spain Hospital Acquired Infection Control Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product

8.3.5.2.2.             By Application

8.3.5.2.3.             By Technology

8.3.5.2.4.             By Disease

8.3.5.2.5.             By End User

9.    North America Hospital Acquired Infection Control Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product

9.2.2.     By Application

9.2.3.     By Technology

9.2.4.     By Disease

9.2.5.     By End User

9.2.6.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Hospital Acquired Infection Control Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product

9.3.1.2.2.             By Application

9.3.1.2.3.             By Technology

9.3.1.2.4.             By Disease

9.3.1.2.5.             By End User

9.3.2.     Mexico Hospital Acquired Infection Control Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product

9.3.2.2.2.             By Application

9.3.2.2.3.             By Technology

9.3.2.2.4.             By Disease

9.3.2.2.5.             By End User

9.3.3.     Canada Hospital Acquired Infection Control Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product

9.3.3.2.2.             By Application

9.3.3.2.3.             By Technology

9.3.3.2.4.             By Disease

9.3.3.2.5.             By End User

10.  South America Hospital Acquired Infection Control Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Product

10.2.2.  By Application

10.2.3.  By Technology

10.2.4.  By Disease

10.2.5.  By End User

10.2.6.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Hospital Acquired Infection Control Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product

10.3.1.2.2.           By Application

10.3.1.2.3.           By Technology

10.3.1.2.4.           By Disease

10.3.1.2.5.           By End User

10.3.2.  Argentina Hospital Acquired Infection Control Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product

10.3.2.2.2.           By Application

10.3.2.2.3.           By Technology

10.3.2.2.4.           By Disease

10.3.2.2.5.           By End User

10.3.3.  Colombia Hospital Acquired Infection Control Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product

10.3.3.2.2.           By Application

10.3.3.2.3.           By Technology

10.3.3.2.4.           By Disease

10.3.3.2.5.           By End User

11.  Middle East and Africa Hospital Acquired Infection Control Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Product

11.2.2.  By Application

11.2.3.  By Technology

11.2.4.  By Disease

11.2.5.  By End User

11.2.6.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Hospital Acquired Infection Control Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Product

11.3.1.2.2.           By Application

11.3.1.2.3.           By Technology

11.3.1.2.4.           By Disease

11.3.1.2.5.           By End User

11.3.2.  Saudi Arabia Hospital Acquired Infection Control Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Product

11.3.2.2.2.           By Application

11.3.2.2.3.           By Technology

11.3.2.2.4.           By Disease

11.3.2.2.5.           By End User

11.3.3.  UAE Hospital Acquired Infection Control Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Product

11.3.3.2.2.           By Application

11.3.3.2.3.           By Technology

11.3.3.2.4.           By Disease

11.3.3.2.5.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Players Profiled

14.2.1.  Becton, Dickinson and Company

14.2.2.  Steris Corporation Ltd.

14.2.3.  Advanced Sterilization Products (U.S., a division of Ethicon US, LLC)

14.2.4.  Getinge Group

14.2.5.  Kimberly-Clark Corporation

14.2.6.  Cantel Medical Corporation

14.2.7.  BioMérieux SA

14.2.8.  Belimed AG

14.2.9.  3M company

14.2.10.                Sterigenics International LLC.

14.2.11.                Synergy Health PLC

14.2.12.                Olympus Corporation Ltd.

14.2.13.                Danaher Corporation Ltd. (Cepheid)

14.2.14.                Crosstex International, Inc.

14.2.15.                Diversey Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com